Stuart A. Scott, PhD, FACMG
Stanford University
H-index: 58
North America-United States
Top articles of Stuart A. Scott, PhD, FACMG
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing | Clinical and Translational Science | Callan Russell MaryAnn Campion Megan E Grove Kelly Matsuda Teri E Klein | 2024/3 |
Clinical Genetics and Referrals | George A Diaz Francis J McMahon Stuart A Scott Randi J Hagerman Antonie D Kline | 2024/1/1 | |
P525: Medical genetics providers require training and institutional support to integrate pharmacogenomic testing | Genetics in Medicine Open | John Imbrie Christina Tise Kendall Schmidt Hetanshi Naik Stuart Scott | 2024/1/1 |
Germline pharmacogenomics in cancer treatment | Victoria M Pratt Stuart A Scott | 2024/1/1 | |
P179: The ClinGen Pharmacogenomics Working Group: Developing frameworks for evaluating pharmacogenomic gene validity and actionability | Genetics in Medicine Open | Li Gong Michelle Whirl-Carrillo Stuart Scott Kelly Caudle Ann Moyer | 2024/1/1 |
Pharmacogenomic Cases: Clopidogrel for Coronary Artery Disease | Stuart A Scott | 2024/1/1 | |
Applications of genome sequencing as a single platform for clinical constitutional genetic testing | Yao Yang Daniela del Gaudio Avni Santani Stuart A Scott | 2024/3/20 | |
Pharmacogenomic Cases: Thiopurine for Acute Lymphoblastic Leukemia | Stuart A Scott | 2024/1/1 | |
Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort | Clinical Pharmacology & Therapeutics | Anna M Mc Laughlin Thomas Helland Fenja Klima Stijn LW Koolen Ron HN van Schaik | 2024/3/18 |
Pharmacogenomic Cases: Warfarin for Atrial Fibrillation | Stuart A Scott | 2024/1/1 | |
P118: Genotype-phenotype correlations in a female with a chromosome Xp11. 23 deletion including PORCN and EBP | Genetics in Medicine Open | Sara Berger Lakshmi Mehta Stuart Scott | 2023/1/1 |
The Genetic Testing Reference Materials Coordination Program: Over 10 Years of Support for Pharmacogenomic Testing | The Journal of Molecular Diagnostics | Stuart A Scott | 2023/9/1 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin … | Clinical Pharmacology & Therapeutics | Katherine N Theken Craig R Lee Li Gong Kelly E Caudle Christine M Formea | 2020/8 |
Stem Cell Modeling of a Candidate Genetic Variant in a Family With Complex Inherited Cardiomyopathy | Circulation | Anna Kirillova Siyi Jiang Yassmin Al Aaraj Chloe Reuter Yunshan Yue | 2023/11/7 |
An efficient genotyper and star-allele caller for pharmacogenomics | Genome Research | Ananth Hari Qinghui Zhou Nina Gonzaludo John Harting Stuart A Scott | 2023/1/1 |
CYP3A4 and CYP3A5 genotyping recommendations: a joint consensus recommendation of the association for molecular Pathology, clinical pharmacogenetics implementation Consortium … | Victoria M Pratt Larisa H Cavallari Makenzie L Fulmer Andrea Gaedigk Houda Hachad | 2023/9/1 | |
Long-read Sequencing for Germline Pharmacogenomic Testing | Advances in Molecular Pathology | Matthew Neu Yao Yang Stuart A Scott | 2023/11/1 |
Secondary Logo Journal Logo | International Journal of Gynecological Pathology | Charlotte FRC Aird Dara LMD Aisner Jill Alldredge Julieta EMD Barroeta Rolland-Jozsef Bartalis | 2023/7 |
Prescriber Adoption of SLCO1B1 Genotype‐Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program | Clinical Pharmacology & Therapeutics | Aniwaa Owusu Obeng Stuart A Scott Tom Kaszemacher Stephen B Ellis Ana Mejia | 2023/2 |
Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics | medRxiv | Guang Yang Pablo González Mariangeli Moneró Kelvin Carrasquillo Jessicca Y Renta | 2023/10/2 |
